Sylvain Célanire

782 total citations
24 papers, 572 citations indexed

About

Sylvain Célanire is a scholar working on Organic Chemistry, Molecular Biology and Immunology. According to data from OpenAlex, Sylvain Célanire has authored 24 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 12 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Sylvain Célanire's work include Receptor Mechanisms and Signaling (8 papers), Mast cells and histamine (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Sylvain Célanire is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Mast cells and histamine (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Sylvain Célanire collaborates with scholars based in France, Belgium and United States. Sylvain Célanire's co-authors include Rob Leurs, Patrice Talaga, Maikel Wijtmans, Iwan J. P. de Esch, Brice Campo, Sonia Poli, Françoise Girard, Emmanuel Le Poul, G. QUEGUINER and Mikhail Kalinichev and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Tetrahedron.

In The Last Decade

Sylvain Célanire

24 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvain Célanire France 13 341 216 169 127 60 24 572
Jamin D. Boggs United States 17 450 1.3× 168 0.8× 393 2.3× 125 1.0× 86 1.4× 24 878
Mark J. Gemkow Germany 11 231 0.7× 115 0.5× 117 0.7× 46 0.4× 116 1.9× 15 389
Curt A. Dvorak United States 19 536 1.6× 182 0.8× 338 2.0× 413 3.3× 91 1.5× 37 1.3k
David Reiner‐Link Germany 13 218 0.6× 53 0.2× 133 0.8× 63 0.5× 83 1.4× 29 418
Kohfuku Kohda Japan 13 305 0.9× 170 0.8× 30 0.2× 101 0.8× 44 0.7× 33 682
Anne Bonnaud France 9 319 0.9× 140 0.6× 54 0.3× 92 0.7× 37 0.6× 13 598
Kathy L. Kohlhaas United States 19 674 2.0× 290 1.3× 41 0.2× 222 1.7× 179 3.0× 33 1.2k
Albert J. Uveges United States 9 401 1.2× 198 0.9× 72 0.4× 46 0.4× 187 3.1× 11 658
Jen Barnes United Kingdom 11 218 0.6× 161 0.7× 32 0.2× 73 0.6× 63 1.1× 15 501
Miguel Guerrero United States 18 694 2.0× 202 0.9× 91 0.5× 79 0.6× 29 0.5× 29 909

Countries citing papers authored by Sylvain Célanire

Since Specialization
Citations

This map shows the geographic impact of Sylvain Célanire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Célanire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Célanire more than expected).

Fields of papers citing papers by Sylvain Célanire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvain Célanire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Célanire. The network helps show where Sylvain Célanire may publish in the future.

Co-authorship network of co-authors of Sylvain Célanire

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvain Célanire. A scholar is included among the top collaborators of Sylvain Célanire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvain Célanire. Sylvain Célanire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eyll, Jonathan van, et al.. (2024). Therapeutic indications for HDAC6 inhibitors in the peripheral and central nervous disorders. Expert Opinion on Therapeutic Targets. 28(9). 719–737. 1 indexed citations
2.
Zhu, Xiaoxia, et al.. (2018). Noise-Induced Hearing Loss in Mice: Effects of High and Low Levels of Noise Trauma in CBA Mice. PubMed. 26. 1210–1213. 6 indexed citations
3.
Motolese, Marta, Federica Mastroiacovo, Milena Cannella, et al.. (2015). Targeting type-2 metabotropic glutamate receptors to protect vulnerable hippocampal neurons against ischemic damage. Molecular Brain. 8(1). 66–66. 28 indexed citations
4.
Kalinichev, Mikhail, Emmanuel Le Poul, Christelle Boléa, et al.. (2014). Characterization of the Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 ADX88178 in Rodent Models of Neuropsychiatric Disorders. Journal of Pharmacology and Experimental Therapeutics. 350(3). 495–505. 55 indexed citations
5.
Célanire, Sylvain & Sonia Poli. (2014). Small Molecule Therapeutics for Schizophrenia. DIAL (Catholic University of Leuven). 15 indexed citations
6.
Provins, Laurent, Sylvain Célanire, B. Christophe, et al.. (2012). Lead Optimization of Thiazolo[5,4‐c]piperidines: 3‐Cyclobutoxy Linker as a Key Spacer for H3R Inverse Agonists. ChemMedChem. 7(12). 2087–2092. 2 indexed citations
7.
Célanire, Sylvain & Brice Campo. (2012). Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders. Expert Opinion on Drug Discovery. 7(3). 261–280. 31 indexed citations
8.
Célanire, Sylvain, B. Christophe, Marie‐Laure Delporte, et al.. (2011). Acetamide Scanning around Bicyclic Thiazoles: SAR at the H3 Receptor. ChemMedChem. 6(9). 1559–1565. 4 indexed citations
9.
Campo, Brice, Mikhail Kalinichev, Nathalie Lambeng, et al.. (2011). Characterization of an mGluR2/3 Negative Allosteric Modulator in Rodent Models of Depression. Journal of Neurogenetics. 25(4). 152–166. 69 indexed citations
10.
Wijtmans, Maikel, Sylvain Célanire, Michel Gillard, et al.. (2010). Histamine H3 receptor ligands with a 3-cyclobutoxy motif: a novel and versatile constraint of the classical 3-propoxy linker. MedChemComm. 1(1). 39–39. 7 indexed citations
11.
Atienzar, Franck A., Sylvain Célanire, B. Christophe, et al.. (2009). Phenyl‐oxazoles, a New Family of Inverse Agonists at the H3 Histamine Receptor. ChemMedChem. 5(2). 206–212. 13 indexed citations
12.
Wijtmans, Maikel, Sylvain Célanire, Erwin Snip, et al.. (2008). 4-Benzyl-1H-imidazoles with Oxazoline Termini as Histamine H3Receptor Agonists. Journal of Medicinal Chemistry. 51(10). 2944–2953. 20 indexed citations
13.
Verrier, Cécile, et al.. (2007). A convenient synthesis of cyclopenta[b]pyridin-2,5-dione as a non- glycosidic cardiotonic agent. ARKIVOC. 2008(7). 92–100. 6 indexed citations
14.
Célanire, Sylvain, Maikel Wijtmans, Patrice Talaga, Rob Leurs, & Iwan J. P. de Esch. (2005). Keynote review: Histamine H3 receptor antagonists reach out for the clinic. Drug Discovery Today. 10(23-24). 1613–1627. 165 indexed citations
15.
Célanire, Sylvain, et al.. (2005). Synthesis of 14-Membered Ring Jaspamide Derivatives. Letters in Organic Chemistry. 2(6). 528–531. 4 indexed citations
16.
17.
18.
19.
Célanire, Sylvain, et al.. (2003). Synthesis of 5-substituted 2-(4- or 3-methoxyphenyl)-4(1 H )-quinolones. Tetrahedron. 59(48). 9627–9633. 12 indexed citations
20.
Célanire, Sylvain, et al.. (1999). First synthesis of (±)-10β-hydroxy-13β-methylcyclohexa[a]quinolizidine. A convenient route to the ABC-part of 8-azasteroids. Tetrahedron. 55(30). 9269–9282. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamin D. Boggs Breakdown of academic impact, for papers by Mark J. Gemkow Breakdown of academic impact, for papers by Curt A. Dvorak Breakdown of academic impact, for papers by David Reiner‐Link Breakdown of academic impact, for papers by Kohfuku Kohda Breakdown of academic impact, for papers by Anne Bonnaud Breakdown of academic impact, for papers by Kathy L. Kohlhaas Breakdown of academic impact, for papers by Albert J. Uveges Breakdown of academic impact, for papers by Jen Barnes Breakdown of academic impact, for papers by Miguel Guerrero
Rankless by CCL
2026